Educational Dissemination for the Implementation of the Covid-19 Health Protocol at Mawar Paud Posts
DOI:
https://doi.org/10.59247/jppmi.v1i9.41Keywords:
Health Protocol, Early Childhood Education, Covid-19Abstract
In this time of the COVID-19 pandemic, it is important to educate children about health protocols. Education on the application of this health protocol is intended so that children at the Mawar Paud Post can understand and know the health protocols that must be applied, namely the 5 M, namely washing hands, maintaining distance, wearing masks, limiting interactions, and staying away from crowds. Based on observations and interviews conducted with early childhood children at the Mawar Paud Post, it was found that there were still many children who did not apply the health protocol (5 M), namely 1) There were still many children who did not wash their hands when entering the classroom, in the event that water and soap have been prepared to wash their hands in front of the class, 2) They don't keep their distance in class, they tend to still like to gather closely with their friends, 3) There are still many preschool children who don't wear masks in the classroom. in the classroom and in the school environment, 4). Do not limit the interaction of fellow friends at school, 5). Do not stay away from the crowd when in the school environment or in the classroom. Early childhood is an important asset for the future of a nation, therefore an effort is needed to introduce them to be able to understand and implement the Covid-19 health protocol effectively. The method used is the experimental design method. To see the results of education based on a questionnaire obtained from pre-test-post-test data. The results showed that there was an increase in knowledge between before being given education on COVID-19 health protocols and after being given education on Covid-19 health protocols.
References
N. Y. Ahn, J. E. Park, D. H. Lee, and P. C. Hong, “Balancing Personal Privacy and Public Safety During COVID-19: The Case of South Korea,” IEEE Access, vol. 8, pp. 171325–171333, 2020, doi: 10.1109/ACCESS.2020.3025971.
L. Carrer et al., “Automatic Pleural Line Extraction and COVID-19 Scoring From Lung Ultrasound Data,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 67, no. 11, pp. 2207–2217, Nov. 2020, doi: 10.1109/TUFFC.2020.3005512.
S. Roy et al., “Deep Learning for Classification and Localization of COVID-19 Markers in Point-of-Care Lung Ultrasound,” IEEE Trans. Med. Imaging, vol. 39, no. 8, pp. 2676–2687, Aug. 2020, doi: 10.1109/TMI.2020.2994459.
S. Tabik et al., “COVIDGR Dataset and COVID-SDNet Methodology for Predicting COVID-19 Based on Chest X-Ray Images,” IEEE J. Biomed. Heal. Informatics, vol. 24, no. 12, pp. 3595–3605, Dec. 2020, doi: 10.1109/JBHI.2020.3037127.
D.-P. Fan et al., “Inf-Net: Automatic COVID-19 Lung Infection Segmentation From CT Images,” IEEE Trans. Med. Imaging, vol. 39, no. 8, pp. 2626–2637, Aug. 2020, doi: 10.1109/TMI.2020.2996645.
X. Wang et al., “A Weakly-Supervised Framework for COVID-19 Classification and Lesion Localization From Chest CT,” IEEE Trans. Med. Imaging, vol. 39, no. 8, pp. 2615–2625, Aug. 2020, doi: 10.1109/TMI.2020.2995965.
A. J. Einstein et al., “International Impact of COVID-19 on the Diagnosis of Heart Disease,” J. Am. Coll. Cardiol., vol. 77, no. 2, pp. 173–185, Jan. 2021, doi: 10.1016/j.jacc.2020.10.054.
N. Minckas et al., “Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due to SARS-CoV-2 infection,” EClinicalMedicine, vol. 33, p. 100733, Mar. 2021, doi: 10.1016/j.eclinm.2021.100733.
L. Bergamaschi et al., “Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease,” Immunity, vol. 54, no. 6, pp. 1257-1275.e8, Jun. 2021, doi: 10.1016/j.immuni.2021.05.010.
P. Serrano-Lorenzo et al., “Plasma LDH: A specific biomarker for lung affectation in COVID-19?,” Pract. Lab. Med., vol. 25, p. e00226, May 2021, doi: 10.1016/j.plabm.2021.e00226.
I. C. Kreft et al., “Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model,” Thromb. Res., vol. 210, pp. 6–11, Dec. 2021, doi: 10.1016/j.thromres.2021.12.015.
S. Ekström et al., “General Stress Among Young Adults with Asthma During the COVID-19 Pandemic,” J. Allergy Clin. Immunol. Pract., vol. 10, no. 1, pp. 108–115, Dec. 2021, doi: 10.1016/j.jaip.2021.10.069.
G. C. Barron et al., “Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection,” Lancet Public Heal., vol. 7, no. 1, pp. e86–e92, Dec. 2021, doi: 10.1016/S2468-2667(21)00235-8.
R. C. Schoonbeek et al., “Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis,” Radiother. Oncol., vol. 167, pp. 42–48, 5593, Dec. 2021, doi: 10.1016/j.radonc.2021.12.005.
N. Hoertel et al., “Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France,” Biol. Psychiatry Glob. Open Sci., vol. 3, no. 1, pp. 56–67, Dec. 2021, doi: 10.1016/j.bpsgos.2021.12.007.
V. Pérez, C. Aybar, and J. M. Pavía, “Dataset of the COVID-19 post-lockdown survey conducted by GIPEyOP in Spain,” Data Br., vol. 40, p. 107763, Dec. 2021, doi: 10.1016/j.dib.2021.107763.
N. P. Mishra et al., “Global impacts of pre- and post-COVID-19 pandemic: Focus on socio-economic consequences,” Sensors Int., vol. 1, p. 100042, 2020, doi: 10.1016/j.sintl.2020.100042.
O. A. Sukocheva et al., “Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome,” J. Adv. Res., vol. 40, pp. 179–196, Nov. 2021, doi: 10.1016/j.jare.2021.11.013.
J. Clemens, A. B. Aziz, B. T. Tadesse, S. Kang, F. Marks, and J. Kim, “Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries,” eClinicalMedicine, vol. 43, p. 101253, Dec. 2021, doi: 10.1016/j.eclinm.2021.101253.
K. Ma et al., “From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors,” Biomed. Pharmacother., vol. 132, p. 110810, Dec. 2020, doi: 10.1016/j.biopha.2020.110810.
D. Bertin et al., “Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome,” Int. J. Infect. Dis., vol. 113, pp. 23–25, Dec. 2021, doi: 10.1016/j.ijid.2021.09.079.
K. Gaspar et al., “Assessing the impact of the COVID-19 lockdown on the energy consumption of university buildings,” Energy Build., vol. 257, p. 111783, Dec. 2021, doi: 10.1016/j.enbuild.2021.111783.
S. Joshi, F. N. Kazmi, I. Sadiq, and T. Azemi, “Post-MI Ventricular Septal Defect During the COVID-19 Pandemic,” JACC Case Reports, vol. 2, no. 10, pp. 1628–1632, Aug. 2020, doi: 10.1016/j.jaccas.2020.06.019.
S. A. Ahmad et al., “Post COVID-19 cerebral venous sinus thrombosis; a case report,” Ann. Med. Surg., vol. 72, p. 103031, Dec. 2021, doi: 10.1016/j.amsu.2021.103031.
V. Mathad and A. Shetty, “Impact of COVID 19 webinar on knowledge, attitude and practices among Indian population- A community based study,” Clin. Epidemiol. Glob. Heal., vol. 13, p. 100919, Dec. 2021, doi: 10.1016/j.cegh.2021.100919.
M. Lucchi, M. Ambrogi, V. Aprile, A. Ribechini, and G. Fontanini, “Laryngotracheal resection for a post-tracheotomy stenosis in a patient with coronavirus disease 2019 (COVID-19),” JTCVS Tech., vol. 4, pp. 360–364, Dec. 2020, doi: 10.1016/j.xjtc.2020.08.023.
A. K. Liemarto, B. P. Budiono, M. A. Chionardes, I. Oliviera, and A. Rahmasiwi, “Liver abscess with necrosis in post COVID-19: A case report,” Ann. Med. Surg., vol. 72, p. 103107, Dec. 2021, doi: 10.1016/j.amsu.2021.103107.
L. H. Willems et al., “Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19,” Thromb. Res., vol. 209, pp. 106–114, Dec. 2021, doi: 10.1016/j.thromres.2021.11.027.
L. Budd and S. Ison, “Responsible Transport: A post-COVID agenda for transport policy and practice,” Transp. Res. Interdiscip. Perspect., vol. 6, p. 100151, Jul. 2020, doi: 10.1016/j.heliyon.2021.e07821.
M. T. H. Le, “Examining factors that boost intention and loyalty to use Fintech post-COVID-19 lockdown as a new normal behavior,” Heliyon, vol. 7, no. 8, p. e07821, Aug. 2021, doi: 10.1016/j.heliyon.2021.e07821.
L. Bettari et al., “Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient,” JACC Case Reports, vol. 2, no. 9, pp. 1279–1283, Jul. 2020, doi: 10.1016/j.jaccas.2020.03.006.
K. A. Earle et al., “Evidence for antibody as a protective correlate for COVID-19 vaccines,” Vaccine, vol. 39, no. 32, pp. 4423–4428, Jul. 2021, doi: 10.1016/j.vaccine.2021.05.063.
A. N. Pelletier, R. P. Sekaly, and J. A. Tomalka, “Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines,” Curr. Opin. Virol., vol. 52, pp. 89–101, Dec. 2021, doi: 10.1016/j.coviro.2021.11.012.
Y. Niu, J. Xian, Z. Lei, X. Liu, and Q. Sun, “Management of infection control and radiological protection in diagnostic radiology examination of COVID-19 cases,” Radiat. Med. Prot., vol. 1, no. 2, pp. 75–80, Jun. 2020, doi: 10.1016/j.radmp.2020.05.005.
A. Mendez-Lopez, D. Stuckler, M. McKee, J. C. Semenza, and J. V. Lazarus, “The mental health crisis during the COVID-19 pandemic in older adults and the role of physical distancing interventions and social protection measures in 26 European countries,” SSM - Popul. Heal., p. 101017, Dec. 2021, doi: 10.1016/j.ssmph.2021.101017.
M. Blofield et al., “A diagonal and social protection plus approach to meet the challenges of the COVID-19 syndemic: cash transfers and intimate partner violence interventions in Latin America,” Lancet Glob. Heal., vol. 10, no. 1, pp. e148–e153, Dec. 2021, doi: 10.1016/S2214-109X(21)00444-7.
S. Bell, R. Clarke, S. Mounier-Jack, J. L. Walker, and P. Paterson, “Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England,” Vaccine, vol. 38, no. 49, pp. 7789–7798, Nov. 2020, doi: 10.1016/j.vaccine.2020.10.027.
M. Dahlan, M. R. Bustami, Makmur, and S. Mas’ulah, “The Islamic principle of ḥifẓ al-nafs (protection of life) and COVID-19 in Indonesia: A case study of nurul iman mosque of Bengkulu city,” Heliyon, vol. 7, no. 7, p. e07541, Jul. 2021, doi: 10.1016/j.heliyon.2021.e07541.
M. Gemperle, S. Grylka-Baeschlin, V. Klamroth-Marganska, T. Ballmer, B. E. Gantschnig, and J. Pehlke-Milde, “Midwives’ perception of advantages of health care at a distance during the COVID-19 pandemic in Switzerland,” Midwifery, vol. 105, p. 103201, Dec. 2021, doi: 10.1016/j.midw.2021.103201.
A. Verma, A. B. Patel, M. C. Tio, and S. S. Waikar, “Caring for Dialysis Patients in a Time of COVID-19,” Kidney Med., vol. 2, no. 6, pp. 787–792, Nov. 2020, doi: 10.1016/j.xkme.2020.07.006.
M. Ndlovu, G. Matipano, and R. Miliyasi, “An analysis of the effect of COVID-19 pandemic on wildlife protection in protected areas of Zimbabwe in 2020,” Sci. African, vol. 14, p. e01031, Nov. 2021, doi: 10.1016/j.sciaf.2021.e01031.
A. S. Alshrari, S. A. Hudu, M. Imran, S. M. B. Asdaq, A. M. Ali, and S. I. Rabbani, “Innovations and development of Covid-19 vaccines: A patent review,” J. Infect. Public Health, vol. 15, no. 1, pp. 123–131, Dec. 2021 doi: 10.1016/j.jiph.2021.10.021.
J. J. Amon, “Human rights protections are needed alongside PPE for health-care workers responding to COVID-19,” Lancet Glob. Heal., vol. 8, no. 7, p. e896, Jul. 2020, doi: 10.1016/S2214-109X(20)30252-7.
C. Leeds, “COVID 19: Health care workers, risks, protection and transmission,” Lancet Reg. Heal. - Eur., vol. 1, p. 100022, Feb. 2021, doi: 10.1016/j.lanepe.2020.100022.
D. Goldblatt et al., “Towards a population-based threshold of protection for COVID-19 vaccines,” Vaccine, vol. 40, no. 2, pp. 306–315, Dec. 2021, doi: 10.1016/j.vaccine.2021.12.006.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Sitti Anggraini, Agnes Dona Tekla
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
